TEBP_HUMAN - dbPTM
TEBP_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TEBP_HUMAN
UniProt AC Q15185
Protein Name Prostaglandin E synthase 3
Gene Name PTGES3
Organism Homo sapiens (Human).
Sequence Length 160
Subcellular Localization Cytoplasm .
Protein Description Cytosolic prostaglandin synthase that catalyzes the oxidoreduction of prostaglandin endoperoxide H2 (PGH2) to prostaglandin E2 (PGE2). [PubMed: 10922363 Molecular chaperone that localizes to genomic response elements in a hormone-dependent manner and disrupts receptor-mediated transcriptional activation, by promoting disassembly of transcriptional regulatory complexes]
Protein Sequence MQPASAKWYDRRDYVFIEFCVEDSKDVNVNFEKSKLTFSCLGGSDNFKHLNEIDLFHCIDPNDSKHKRTDRSILCCLRKGESGQSWPRLTKERAKLNWLSVDFNNWKDWEDDSDEDMSNFDRFSEMMNNMGGDEDVDLPEVDGADDDSQDSDDEKMPDLE
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MQPASAKW
-------CCCCCCCC
10.99-
7Acetylation-MQPASAKWYDRRDY
-CCCCCCCCCCCCCE
43.7323954790
7Ubiquitination-MQPASAKWYDRRDY
-CCCCCCCCCCCCCE
43.7321890473
7Ubiquitination-MQPASAKWYDRRDY
-CCCCCCCCCCCCCE
43.7321890473
7Ubiquitination-MQPASAKWYDRRDY
-CCCCCCCCCCCCCE
43.7321890473
7Ubiquitination-MQPASAKWYDRRDY
-CCCCCCCCCCCCCE
43.7321890473
14PhosphorylationKWYDRRDYVFIEFCV
CCCCCCCEEEEEEEE
8.7522817900
24PhosphorylationIEFCVEDSKDVNVNF
EEEEEECCCCCEEEE
19.7629759185
33MalonylationDVNVNFEKSKLTFSC
CCEEEEEECCEEEEE
49.0726320211
33UbiquitinationDVNVNFEKSKLTFSC
CCEEEEEECCEEEEE
49.0721890473
33SumoylationDVNVNFEKSKLTFSC
CCEEEEEECCEEEEE
49.0719608861
33UbiquitinationDVNVNFEKSKLTFSC
CCEEEEEECCEEEEE
49.0721890473
33UbiquitinationDVNVNFEKSKLTFSC
CCEEEEEECCEEEEE
49.0721890473
33MethylationDVNVNFEKSKLTFSC
CCEEEEEECCEEEEE
49.0719608861
33AcetylationDVNVNFEKSKLTFSC
CCEEEEEECCEEEEE
49.0719608861
33SumoylationDVNVNFEKSKLTFSC
CCEEEEEECCEEEEE
49.07-
33UbiquitinationDVNVNFEKSKLTFSC
CCEEEEEECCEEEEE
49.0721906983
34PhosphorylationVNVNFEKSKLTFSCL
CEEEEEECCEEEEEC
26.2128450419
35SumoylationNVNFEKSKLTFSCLG
EEEEEECCEEEEECC
63.72-
35UbiquitinationNVNFEKSKLTFSCLG
EEEEEECCEEEEECC
63.7221890473
35UbiquitinationNVNFEKSKLTFSCLG
EEEEEECCEEEEECC
63.7221890473
35SumoylationNVNFEKSKLTFSCLG
EEEEEECCEEEEECC
63.7228112733
35AcetylationNVNFEKSKLTFSCLG
EEEEEECCEEEEECC
63.7223749302
35UbiquitinationNVNFEKSKLTFSCLG
EEEEEECCEEEEECC
63.7221890473
35UbiquitinationNVNFEKSKLTFSCLG
EEEEEECCEEEEECC
63.7221890473
35AcetylationNVNFEKSKLTFSCLG
EEEEEECCEEEEECC
63.72-
37PhosphorylationNFEKSKLTFSCLGGS
EEEECCEEEEECCCC
19.7628450419
39PhosphorylationEKSKLTFSCLGGSDN
EECCEEEEECCCCCC
11.8229255136
40S-nitrosocysteineKSKLTFSCLGGSDNF
ECCEEEEECCCCCCC
3.41-
40S-nitrosylationKSKLTFSCLGGSDNF
ECCEEEEECCCCCCC
3.4119483679
40GlutathionylationKSKLTFSCLGGSDNF
ECCEEEEECCCCCCC
3.4122555962
44PhosphorylationTFSCLGGSDNFKHLN
EEEECCCCCCCCCCC
27.8129255136
48AcetylationLGGSDNFKHLNEIDL
CCCCCCCCCCCCEEE
54.13-
48UbiquitinationLGGSDNFKHLNEIDL
CCCCCCCCCCCCEEE
54.1321890473
48UbiquitinationLGGSDNFKHLNEIDL
CCCCCCCCCCCCEEE
54.1321890473
48MethylationLGGSDNFKHLNEIDL
CCCCCCCCCCCCEEE
54.1371275
48AcetylationLGGSDNFKHLNEIDL
CCCCCCCCCCCCEEE
54.1323749302
48UbiquitinationLGGSDNFKHLNEIDL
CCCCCCCCCCCCEEE
54.1321906983
58GlutathionylationNEIDLFHCIDPNDSK
CCEEEEEEECCCCCC
2.7122555962
64PhosphorylationHCIDPNDSKHKRTDR
EEECCCCCCCCCCCC
43.2128450419
65UbiquitinationCIDPNDSKHKRTDRS
EECCCCCCCCCCCCE
56.8821890473
65UbiquitinationCIDPNDSKHKRTDRS
EECCCCCCCCCCCCE
56.8821890473
652-HydroxyisobutyrylationCIDPNDSKHKRTDRS
EECCCCCCCCCCCCE
56.88-
65SumoylationCIDPNDSKHKRTDRS
EECCCCCCCCCCCCE
56.88-
65UbiquitinationCIDPNDSKHKRTDRS
EECCCCCCCCCCCCE
56.8821906983
65SumoylationCIDPNDSKHKRTDRS
EECCCCCCCCCCCCE
56.8828112733
65AcetylationCIDPNDSKHKRTDRS
EECCCCCCCCCCCCE
56.8825953088
67UbiquitinationDPNDSKHKRTDRSIL
CCCCCCCCCCCCEEE
61.81-
67UbiquitinationDPNDSKHKRTDRSIL
CCCCCCCCCCCCEEE
61.81-
69PhosphorylationNDSKHKRTDRSILCC
CCCCCCCCCCEEEEE
40.3423312004
72PhosphorylationKHKRTDRSILCCLRK
CCCCCCCEEEEEEEC
23.7920873877
75S-nitrosocysteineRTDRSILCCLRKGES
CCCCEEEEEEECCCC
1.64-
75S-palmitoylationRTDRSILCCLRKGES
CCCCEEEEEEECCCC
1.6429575903
75S-nitrosylationRTDRSILCCLRKGES
CCCCEEEEEEECCCC
1.6419483679
76S-nitrosylationTDRSILCCLRKGESG
CCCEEEEEEECCCCC
3.5519483679
76S-palmitoylationTDRSILCCLRKGESG
CCCEEEEEEECCCCC
3.5529575903
76S-nitrosocysteineTDRSILCCLRKGESG
CCCEEEEEEECCCCC
3.55-
79UbiquitinationSILCCLRKGESGQSW
EEEEEEECCCCCCCC
54.8221890473
79UbiquitinationSILCCLRKGESGQSW
EEEEEEECCCCCCCC
54.8221890473
79AcetylationSILCCLRKGESGQSW
EEEEEEECCCCCCCC
54.8226051181
79SumoylationSILCCLRKGESGQSW
EEEEEEECCCCCCCC
54.82-
79SumoylationSILCCLRKGESGQSW
EEEEEEECCCCCCCC
54.82-
79UbiquitinationSILCCLRKGESGQSW
EEEEEEECCCCCCCC
54.8221890473
82PhosphorylationCCLRKGESGQSWPRL
EEEECCCCCCCCCCC
51.2923927012
85PhosphorylationRKGESGQSWPRLTKE
ECCCCCCCCCCCCHH
42.4423401153
90PhosphorylationGQSWPRLTKERAKLN
CCCCCCCCHHHHHCC
31.9429514088
91UbiquitinationQSWPRLTKERAKLNW
CCCCCCCHHHHHCCE
50.20-
91AcetylationQSWPRLTKERAKLNW
CCCCCCCHHHHHCCE
50.2011921337
95SumoylationRLTKERAKLNWLSVD
CCCHHHHHCCEEEEC
48.88-
95UbiquitinationRLTKERAKLNWLSVD
CCCHHHHHCCEEEEC
48.8821890473
95SumoylationRLTKERAKLNWLSVD
CCCHHHHHCCEEEEC
48.88-
95UbiquitinationRLTKERAKLNWLSVD
CCCHHHHHCCEEEEC
48.8821890473
100PhosphorylationRAKLNWLSVDFNNWK
HHHCCEEEECCCCCC
15.9722617229
113 (in isoform 4)Phosphorylation-56.0425849741
113PhosphorylationWKDWEDDSDEDMSNF
CCCCCCCCCCCCCHH
56.0419664994
118 (in isoform 3)Phosphorylation-46.8222210691
118PhosphorylationDDSDEDMSNFDRFSE
CCCCCCCCHHHHHHH
46.8222167270
118 (in isoform 4)Phosphorylation-46.8225849741
121 (in isoform 3)Phosphorylation-55.7722210691
124 (in isoform 4)Phosphorylation-26.0223663014
124PhosphorylationMSNFDRFSEMMNNMG
CCHHHHHHHHHHHCC
26.0223927012
127 (in isoform 4)Phosphorylation-2.6226055452
130 (in isoform 4)Phosphorylation-5.5825159151
148PhosphorylationVDGADDDSQDSDDEK
CCCCCCCCCCCCCCC
42.7723927012
151PhosphorylationADDDSQDSDDEKMPD
CCCCCCCCCCCCCCC
39.0523927012

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
113SPhosphorylationKinaseCSNK2A1P68400
GPS
118SPhosphorylationKinaseCSNK2A1P68400
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TEBP_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TEBP_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
MCR_HUMANNR3C2physical
10691735
GCR_HUMANNR3C1physical
10691735
TERT_HUMANTERTphysical
10197982
HS90A_HUMANHSP90AA1physical
14761955
CHIP_HUMANSTUB1physical
20661446
FKBP5_HUMANFKBP5physical
20661446
FKBP2_HUMANFKBP2physical
20661446
PPP5_HUMANPPP5Cphysical
20661446
AIP_HUMANAIPphysical
20661446
DNJC7_HUMANDNAJC7physical
20661446
WAP53_HUMANWRAP53physical
22939629
URM1_HUMANURM1physical
22939629
KAT2A_HUMANKAT2Aphysical
23022381
HS90A_HUMANHSP90AA1physical
23022381
SURF1_HUMANSURF1physical
21988832
ANDR_HUMANARphysical
22899854
TEBP_HUMANPTGES3physical
10811660
DNM3A_HUMANDNMT3Aphysical
8772199
DNM3A_MOUSEDnmt3aphysical
8772199
THA_HUMANTHRAphysical
10691735
HS90A_HUMANHSP90AA1physical
11447118
E2AK2_HUMANEIF2AK2physical
11447118
TEBP_HUMANPTGES3physical
10543959
HS90B_HUMANHSP90AB1physical
10543959
HS90A_HUMANHSP90AA1physical
22806877
HS90B_HUMANHSP90AB1physical
17010336
HS90A_HUMANHSP90AA1physical
18172314
HS90A_HUMANHSP90AA1physical
10642522
CALR_HUMANCALRphysical
26344197
CALU_HUMANCALUphysical
26344197
NACA2_HUMANNACA2physical
26344197
PACN2_HUMANPACSIN2physical
26344197
RBP2_HUMANRANBP2physical
26344197
STIP1_HUMANSTIP1physical
26344197
TKT_HUMANTKTphysical
26344197
AIP_HUMANAIPphysical
11013261
AHR_HUMANAHRphysical
11013261
HS90A_HUMANHSP90AA1physical
19740745
EGLN1_HUMANEGLN1physical
23413029
AHSA1_HUMANAHSA1physical
22504172
HS90A_HUMANHSP90AA1physical
18285346
HS90B_HUMANHSP90AB1physical
18285346
HS90A_HUMANHSP90AA1physical
14987994
HS90A_CHICKHSP90AA1physical
12324468
HS90A_HUMANHSP90AA1physical
11413142
FKBP4_HUMANFKBP4physical
11413142
PPID_HUMANPPIDphysical
11413142
HS90A_HUMANHSP90AA1physical
16403413
HS90A_HUMANHSP90AA1physical
22504172
CDC37_HUMANCDC37physical
22504172
HS90A_HUMANHSP90AA1physical
26151834
EGLN1_HUMANEGLN1physical
24711448

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TEBP_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1; LYS-7 AND LYS-33, ANDMASS SPECTROMETRY.
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey.";
Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.;
Mol. Cell 23:607-618(2006).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-33, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND MASSSPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113; SER-148 ANDSER-151, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113; SER-148 ANDSER-151, AND MASS SPECTROMETRY.
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography.";
Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.;
Proteomics 8:1346-1361(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113; SER-148 ANDSER-151, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113; SER-148 ANDSER-151, AND MASS SPECTROMETRY.
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment.";
Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
J. Proteome Res. 7:5167-5176(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND MASSSPECTROMETRY.
"Phosphoproteome of resting human platelets.";
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.;
J. Proteome Res. 7:526-534(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND MASSSPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND MASSSPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-148 AND SER-151, ANDMASS SPECTROMETRY.
"Toward a global characterization of the phosphoproteome in prostatecancer cells: identification of phosphoproteins in the LNCaP cellline.";
Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.;
Electrophoresis 28:2027-2034(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND MASSSPECTROMETRY.
"Phosphoproteomic analysis of the human pituitary.";
Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F.;
Pituitary 9:109-120(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113; SER-118; SER-148AND SER-151, AND MASS SPECTROMETRY.
"Quantitative phosphoproteome analysis using a dendrimer conjugationchemistry and tandem mass spectrometry.";
Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,Bodenmiller B., Watts J.D., Hood L., Aebersold R.;
Nat. Methods 2:591-598(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND MASSSPECTROMETRY.

TOP